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MAJOR histocompatibility complex (MHC) class I molecules bind
and deliver peptides derived from endogenously synthesized pro-
teins to the cell surface for survey by cytotoxic Τ lymphocytes. It
is believed that endogenous antigens are generally degraded in the
cytosol, the resulting peptides being translocated into the endoplas-
mic reticulum where they bind to MHC class I molecules. Trans-
porters containing an ATP-binding cassette encoded by the MHC
TABLE 1 Presentation of the mmor histocompatibility antigen HA-2 by T2
cells transfected w th transporter genes
Target cells
X
Υ
T l
T2
T2/TAP1
T2/TAP2
T2/TAP1+2
Effector cel's
Anti-HLA-A2 1 allo
10 1
71
72
96
100
IOC
8 1
8 2
1 1
57
60
82
87
83
6 1
75
Anti-HA-2
10 1
68
55
71
0
0
5
57
1 1
43
26
64
1
3
5
26
10
1
0
10
2
0
3
0
Q66 9
1 1 1
1
0
5
1
1
1
0
T2 cells transfected with rat TAP1" and TAP2" cDNAs were tested for
their capacity to present the endogenously synthesized mmor histocompati-
bility antigen HA-2 to an HLA-A21-restricted mmor histocompatibility anti-
gen HA-2-specific CTL clone T2 cells transfected with both transporter
genes but not the untransfected T2 could present the HA-2 antigen An
alloreactive CTL clone specific for HLA-A21 and the influenza matnx'specific
CTL clone Q66 9 (see Table 2a) were included as controls The HA-2-specific
CTL clone, designated HA-2 (ref 25), and the HLA A21 alloreactive CTL
clone26 were mixed with chromium-labelled targets at effector-to-target
ratlos of 10 1 and 1 1, and specific lysis was measured in a 4-h chromium
release assay, values represent por cent specific lysis X and Υ are lympho-
blastoid cell lines transformed by Epstein-Barr virts and obtained from
HLA-A21-positive healthy individuals
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TABLE 2 Presentation of influenza matnx protein M l by T2 cells transfected
(a)
Target cells
X
Υ
JY
T l
T2
T2/TAP1
T2/TAP2
T2/TAP1+2
(b)
Target cells
JY
T l
T2
T2/TAP1
T2/TAP2
T2/TAP1 + 2
with transporter {jenes
Q66 9 Effector
Influenza virus infected
(expt 1)
5 1
28
33
n t
50
7
8
4
26
0 5 1
14
15
n t
18
4
3
1
7
(expt 2)
5 1
n t
n t
3 1
62
8
12
5
33
Ml-vac infected
(expt
10 1
72
78
4
14
7
49
1)
0 6 1
32
22
1
6
2
16
0 5
n t
n t
7
17
3
5
2
11
4-30
10
8
1 1
8
2
1
7
M l
1 5 1
3
0
3
0
7
6
6
0
cells
peptide
0
0 5 :
0
0
0
0
3
4
0
0
Effector cells
i 58-66
Ι μ ί
1 5 1
23
30
23
68
71
62
70
73
added
• m r 1
05 1
14
12
14
19
21
3 1
25
29
M l peptide 58-66 added
0
1 0 6 1
1
3
0
2
0
2
2 5 μg ml" 1
10 1
80
68
80
67
77
75
06 1
24
24
21
14
21
17
Control cells and T2 cells transfected with rat TAPla and TAP2a were
infected overmght with influenza virus Hongkong 68 and then tested for
HLA-A21-mediated presentation of the influenza matnx antigen using the
CTL clone Q66 9 The results from two representative expenments are
shown (a) In additional expenments using recombinant vaccinia virus pro-
ducing matnx protein (Ml-vac) and the Ml-specific CTL line 4-30, similar
results were obtained (6) Table 2 also shows that all cell lines function as
targets after preincubation with exogenously added influenza matnx peptide
M58-66 (sequence ILGFVFTLTV) (a) Where indicated, target cells were
infected overmght with influenza virus Hongkong 68 Q66 9 is a CTL clone
recognizing the influenza matnx-denved peptide M58-66 restricted by HLA-
A21 This clone was raised against the synthetic peptide M58-66 (HS,
unpubhshed) Lysis was determined in a 4-h chromium-release assay at
effector-to-target ratios of 5 1 and 0 5 1 For presentation of exogenously
added peptide, target cells were preincubated with M58-66 peptide at
1 μg m r 1 for 2 h before addition of the CTL clone Q66 9 (b) Target cells
were infected with Ml-vac27 (20 PFU per cell) for 3 h 4-30 is a fresh CTL
line from an HLA-A21-positive donor raised against the synthetic peptide
M55-73 (P W, unpubhshed) Lysis was determined in a 5-h chromium-release
assay at effector-to-target ratios ranging from 10 1 to 0 3 1 M58-66
peptide was added as a control 15 min before addition of CTL at 2 5 μg ml" 1
class II region seem to be responsible for this transport1"8. Genes
coding for two subunits of the '20S' proteasome (a multicatalytic
proteinase) have been found in the vicinity of the two transporter
genes in the MHC class II region, indicating that the proteasome
could be the unknown proteolytic entity in the cytosol involved in
the generation of MHC class I-binding peptides9""13. By introduc-
ing rat genes encoding the MHC-linked transporters into a human
cell line lacking both transporter and proteasome subunit genes,
we show here that the MHC-encoded proteasome subunits are not
essential for stable MHC class I surface expression, or for proces-
sing and presentation of antigenic peptides from influenza virus
and an intracellular protein.
The 20S proteasome consists of about 20-30 subunits with
M,s between 15,000 and 30,000 that are encoded by distinct sets
of genes14. We used the human lymphoblastoid Β cell-denved
mutant T2 line to investigate whether or not the MHC-linked
proteasome subunits are essential for MHC class I expression
and antigen presentation. T2 has a large homozygous deletion
of the MHC class II region15, which encompasses the genes for
the two ATP-binding cassette (ABC) transporter polypeptides,
TAP1 and TAP2, and the two genes for the MHC-encoded
proteasome subunits, Lmp2 and Lmp7. In the absence of trans-
porters, most HLA class I molecules are devoid of the peptides
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FIG 1 Restoration of HLA class I expression on T2 cells
transfected with transporter genes The cDNAs for the two
rat transporter chains TAPla and TAP2a were used
individually or as a mixture to transfect T2 cells HLA cell-
surface expression was measured by cytofluorometry In five
independent cotransfections with TAP1 and TAP2 we always
obtained a substantial fraction of cells expressing high levels
of HLA class I, similar to the example shown here
METHODS In each expenment, ΙΟ 7 Τ2 cells were transfected
by electroporation with ~ 2 μg each of rat cDNAs TAPla
(mtpla, clone 510-15) or TAP2a (mtp2a, clone 441-11) in
the pHßAPr-1-neo expression vector 1 5 2 i Both plasmids con-
tain the /3-actin promoter and the neomycin-resistance gene
Selection was in 1 mg m l " 1 G418 (Gibco) After 4 to 6 weeks,
cytofluorometry was done with the bulk cultures usmg a
FACScan (Becton and Dickinson) Antibodies used were Tu lO l
against HLA-A2 (ref 28), TulO9 against HLA-Bw4 (ref 29),
and 2 06 against HLA-DR, -DP and -DQ (ref 30), detected by
fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse
IgG (Sigma) Stainmg with antibodies Tu48 (HLA-Bw4, ref 31)
and BB7 2 (HLA-A2; ref 32) yielded comparable results,
except that BB7 2 stained HLA-A2 antigens on untransfected
T2 cells more strongly than antibody Tu lOl The unseparated
bulk culture of T2 cotransfected with both transporters
yielded a broad peak containing both negative and positive
cells Bottom row shows stainmg profiles of T2/TAP1 + 2 en-
riched by cell sorting for high expression of HLA-B5 usmg
antibody TulO9 and FACStar Plus cell sorter
Tu 101 (HLA-A2) Tu109 (HLA-B5) 2 06 (HLA-DR)
100n 100η 100-,
T1
10° 101 102 103 104 10° 101 102 103 104 10° 101 102 103 104
100-, 100 η 100η
T2
10° 101 102 103 104 10° 101 102 103 104 10° 101 102 103 104
100η 100η 100η
T2/TAP1
10° 101 102 103 104 10° 101 102 103 104 10° 101 102 103 104
100η 100η 100η
Τ2/ΤΑΡ2 :
10° 101 102 103 104 10° 101 102 103 104 10° 101 102 103 104
100η 100η 100η
Τ2/
ΤΑΡ1+2
10° 101 102 103 104 10° 101 102 103 104 10° 101 102 103 104
100 h 100-j 100 η
Τ2/
ΤΑΡ1+2 i
sorted
ο
η ι
10° 101 102 103 104 10° 101 102 103 104 10° 101 102 103 104
necessary for stable assembly of the class I heavy chain with
/82-microglobulin and for expression at the cell surface
16
"
18
.
Therefore the T2 cell line shows strongly decreased expression
of HLA-B5 and partially decreased expression of HLA-A2.1
molecules and is deficient in antigen presentation19'20.
We transfected the T2 cells with the rat ABC transporter
complementary DNAs rat TAP1" and rat TAP2", previously
named mtpl" and mtp2", respectively1·5·21. The resulting trans-
fectants were analysed for class I cell-surface expression. Paren-
tal Tl cells, from which T2 cells were derived, were positive for
HLA-A2.1 and -B5 and also for HLA class II molecules, whereas
T2 cells did not stain for HLA-B5 and only weakly for HLA-A2.1
(Fig. 1). Transfection with rat TAP1" alone did not alter HLA
expression. Transfection with TAP2" resulted in a shght increase
of HLA-A2 and HLA-B5 expression, which we are investigating
at present. But when both TAP1" and TAP2" rat transporter
genes were transfected into T2 cells, HLA-A2.1 and HLA-B5
expression was restored to levels two to three times higher than
on Tl cells. Expression of class I in this bulk culture was
improved by sorting for cells expressing high levels of HLA-B5
(bottom panel).
Western blots using sera raised against rat TAP1 and TAP2
showed that the T2/TAP1+2 transfectant expressed the TAP
polypeptides in amounts comparable to rat stram PVG.R19
lymphoblasts stimulated by concanavalin Α (Fig. 2a). The
absence of the MHC-encoded proteasome subunits in the
T2 transfectants was confirmed by immunoprecipitation (not
shown) and messenger RNA analysis (Fig. 2b). It is possible
that in the absence of Lmp2 and Lmp7, peptides of inappropriate
length are generated, which would result in a decreased stability
of the assembled class I molecules. Lysates of biosynthetically
labelled cells were incubated at 37 °C for different times. Class
I molecules were then immunoprecipitated with monoclonal
antibody W6/32, which only recognizes class I molecules associ-
ated with /32-microglobulin. Class I molecules devoid of peptides
are unstable under these conditions and lose the epitope recog-
nized by W6/32 (ref. 22). HLA-A2 and B5 were separated by
one-dimensional isoelectnc focusing (Fig. 2c). Most HLA-A2
molecules expressed in T2 cells are unstable to exposure at
37 °C, whereas most HLA-A2 molecules in Tl cells and T2 cells
reconstituted with TAP1 and TAP2 are stable over a 4-h exposure
to 37 °C. Α more drastic effect of temperature on the stability
of HLA-B5 is evident. HLA-B5 in T2 cells is unstable at 37 °C,
whereas it is stable both in Tl cells and in T2/TAP1 + 2 cells.
Thus, expression of TAP1 and TAP2 in T2 cells results in proper
stabilization of both HLA-A2 and -B5 molecules. These results
demonstrate that expression of transporter polypeptides alone,
in the absence of the MHC-encoded proteasome subunits, is
sufficient for apparently normal and stable class I expression.
Next, T2 cells transfected with rat ΤΑΡ1" and rat TAP2"
were investigated for their ability to process and present
endogenous proteins. For this purpose T2 transfectants were
tested with an HLA-A2.1-restricted cytotoxic Τ lymphocyte
(CTL) clone recognizing a minor histocompatibility antigen
(HA-2). Control cells, including Tl, were lysed, but not T2 cells
or T2 transfected with only one transporter gene (Table 1). In
contrast, T2 cells transfected with both transporter genes were
lysed efficiently. An HLA-A2.1 alloreactive CTL clone included
as a positive control strongly lysed al! transfectants, including
the parental T2 cells. As the HLA-A2.1 molecules on T2 cells
appear to carry only a limited vanety of peptides derived from
signal sequences23'24, our data suggest that the anti-HLA-A2.1
CTL clone recognizes such a signal sequence-derived peptide.
Because the nature of the HA-2 antigen is not yet known, we
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FIG 2 Expression of TAP1 and TAP2 in T2 cells results in stabilization of
HLA-A2 and HLA-B5 molecules a, Expression of ABC transporters in trans-
fectant cells Rat PVG R19 lymphoblasts stimulated with ooncanavahn Α and
lysed in NP40 detergent, and T2 and the Single and double transfectant
cells were probed with rabbit antisera raised against synthetic peptides of
the carboxy termini of rat TAPl a and TAP2a The antisera fail to recognize
matenal in T2 cells but detect rat TAP products in the transfectants Cell
lysis and western blotting were done as described5, each track contains
lysate equivalent to 20,000 cells Antisera recognizing rat TAP1 (ref 5) and
a new, previously undescribed antiserum raised against the rat TAP2 C-
terminal sequence EQDVYAHLVQQRLEA were used at a 1/1,000 dilution b,
Northern blot analysis was used to verify that the T2 cells expressing rat
TAPl a and TAP2a transporters were mdeed negative for expression of the
MHC encoded subumt Lmp7 Lanes show 20 μg (lanes A) or 40 μg (lanes
B) total RNA extracted from each cell line and probed with a cDNA specific
for Lmp7 (isoiated by Uwe Graf and V O N , unpublished) The absence of
the MHC-encoded proteasome subunits was also venfied by immunoprecipi-
tation (not shown) using a rabbit serum against the 20S proteasome1 1 c,
Stability of MHC molecules was assayed by exposing cell lysates to 37 °C
for different times Stable class I molecules were recovered with the
monoclonal antibody W6/32 Both HLA-A2 and -B5 molecules are stabilized
by expressing TAP1 and TAP2 in T2 cells and regain a similar stability as
class I molecules in T l cells We labelled 1 4 x l O 6 Τ Ι , Τ2 or T2/TAP1 + 2
cells for 15 min with 200 μ & 35S-methionine and cysteine, respectively
c HLA-A2 HLA-B5
T2/TAP1+2 **• * * m «· «ι,,*)*ί
Time (mm) ο 15 30 60 120 240 0 15 30 60 120240
Cells were lysed in NP40 lysis mixture and their nuclei removed Lysates
were precleared with normal rabbit serum and equal amounts incubated at
37 °C for the times indicated After preclearmg agam with normal rabbit
serum, class I molecules were immunoprecipitated with monoclonal antibody
W6/32 Immunoprecipitates were analysed by one-dimensional isoelectric
focusing22, only HLA-A2 and -B5 molecules are shown
analysed the processing of a well-defined antigen, influenza
virus matrix protein. Cells were infected overnight with influenza
virus and then used as targets for the CTL clone Qo6.9, which
recognizes the influenza matrix-derived peptide epitope M58-66
restricted by HLA-A2.1. Representative experiments in Table
2a show that infected Tl cells, the HLA-A2.1-pcsitive cell line
JY, and X and Υ targets weie killed, but not T2 cells or T2
transfected with the individual transporter genes. In contrast,
the T2/TAP1 + 2 cells expressing both transporter polypeptides
were lysed. This lysis (26 and 33% at a 5.1 effector to target
ratio) was weaker than the lysis of Tl cells (50% and 62%,
respectively) but with the other influenza virus-infected cell
lines, JY, X and Y, only 28 to 33% lysis was again obtained.
Results were comparable when target cells were infected with
a recombinant vaccinia virus making the influenza Ml matrix
protein (Ml-vac) and the Ml-specific CTL line 4-30 was used
(Table 2b). Lysis of Ml-vac-infected T2/TAP1 + 2 cells was
again less than lysis of Ml-vac-infected Tl cells. All transfectants
were able to present the synthetic matrix peptide M58-66 when
it was added exogenously. It is clear from these data that the
capacity to form and present this influenza epitope has been
returned to the T2/TAP1 + 2 transfectant, although it is possible
that this capacity is suboptimal.
We conclude that the heterodimeric MHC-encoded transpor-
ter is alone sufficient for MHC class I-mediated antigen pres-
entation, at least for the two antigens tested here. Thus, there
does not seem to be an absolute requirement for the MHC-linked
proteasome subunits Lmp2 and Lmp7. Our observations could
mean that the presence of genes encoding two of the proteasomes
in the MHC may be fortuitous and that the 20S proteasome
does not play a role in antigen presentation. It is also possible
however that the proteasome is only one of several proteolytic
enzymes with the capacity to digest cytosohc antigen into class
I-binding peptides. Α proteasome lacking the MHC-encoded
subunits may well have adequate proteolytic activity and could
be the source of peptides assembled in our T2/TAP1 + 2 transfec-
tant. The MHC-encoded proteasome subunits, which are induc-
ible by Interferon-γ, may nevertheless function to increase the
overall proteolytic activity or the ränge of peptides generated
by the proteasome from antigens in the context of an immune
response, to a virus for example. Investigation of T2 cells
restored with transporters and of the MHC-encoded proteasome
subunits will help to clarify this issue. •
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